Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tristel hails "another strong year" as profit and revenue advance

13th Oct 2025 12:25

(Alliance News) - Tristel PLC on Monday backed its ability to deliver revenue growth and strong profitability, as it posted a near 20% gain in full-year profit.

The Newmarket, England-based maker of infection prevention products reported pretax profit of GBP8.4 million for the financial year that ended June 30, up 19% from GBP7.1 million a year earlier.

Driving the advance was an 11% top-line gain, as revenue rose to GBP46.5 million from GBP41.9 million.

Tristel credited this improvement to a combination of higher sales volumes and price increases.

The company reported an 11% gain in medical device sales to GBP40.4 million from GBP36.4 million, with this reinforcing its "ability to continually grow on [its] market leadership position."

Tristel did face increased administrative expenses during the period, up 9.3% to GBP28.7 million from GBP26.2 million, limiting bottom line gains.

Shares in the company were down 0.3% to 356.80 pence midday Monday in London.

Tristel declared a final dividend of 8.52p, up from 8.28p a year before, making for a total annual dividend of 14.20p per share, up 5.0% from 13.52p.

Commenting on trading since the start of the new financial year in July, Tristel said demand in the US "remains significant", as it noted a high volume of leads with engagement across around 200 health systems.

Anna Wasyl started as chief financial officer last month, replacing Liz Dixon, who departed in June.

"Tristel has delivered another strong year...This performance reflects the strength of our core business, robust cash generation and continued disciplined execution, enabling us to increase the dividend while maintaining a debt-free balance sheet," said Chief Executive Matt Sassone.

"With Anna joining the board, new product launches...and a solid cash position, the board remains confident in our ability to deliver sustained revenue growth, strong profitability, and attractive shareholder returns."

By Christopher Ward, Alliance News reporter

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

Tristel
FTSE 100 Latest
Value9,436.09
Change11.34